These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25038114)

  • 1. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.
    Harboe ZB; Larsen MV; Ladelund S; Kronborg G; Konradsen HB; Gerstoft J; Larsen CS; Pedersen C; Pedersen G; Obel N; Benfield T
    Clin Infect Dis; 2014 Oct; 59(8):1168-76. PubMed ID: 25038114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors for invasive pneumococcal disease in HIV-positive individuals in the era of highly active antiretroviral therapy.
    Sadlier C; O'Connell S; Kelleher M; Bergin C
    Int J STD AIDS; 2019 Apr; 30(5):472-478. PubMed ID: 30999829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.
    Barry PM; Zetola N; Keruly JC; Moore RD; Gebo KA; Lucas GM
    AIDS; 2006 Feb; 20(3):437-44. PubMed ID: 16439878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.
    Harboe ZB; Dalby T; Weinberger DM; Benfield T; Mølbak K; Slotved HC; Suppli CH; Konradsen HB; Valentiner-Branth P
    Clin Infect Dis; 2014 Oct; 59(8):1066-73. PubMed ID: 25034421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
    Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
    Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
    Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
    Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
    Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
    Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012.
    von Mollendorf C; Cohen C; de Gouveia L; Naidoo N; Meiring S; Quan V; Lindani S; Moore DP; Reubenson G; Moshe M; Eley B; Hallbauer UM; Finlayson H; Madhi SA; Conklin L; Zell ER; Klugman KP; Whitney CG; von Gottberg A;
    Pediatr Infect Dis J; 2015 Jan; 34(1):27-34. PubMed ID: 24992122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System.
    Marcus JL; Baxter R; Leyden WA; Muthulingam D; Yee A; Horberg MA; Klein DB; Towner WJ; Chao CR; Quesenberry CP; Silverberg MJ
    AIDS Patient Care STDS; 2016 Oct; 30(10):463-470. PubMed ID: 27749111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014.
    Chowers M; Regev-Yochay G; Mor O; Cohen-Poradosu R; Riesenberg K; Zimhony O; Chemtob D; Stein M; Dagan R; Levy I
    Hum Vaccin Immunother; 2017 Jan; 13(1):216-219. PubMed ID: 27648488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
    Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
    Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease.
    Grau I; Ardanuy C; Liñares J; Podzamczer D; Schulze MH; Pallares R
    HIV Med; 2009 Sep; 10(8):488-95. PubMed ID: 19459987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.
    Yin Z; Rice BD; Waight P; Miller E; George R; Brown AE; Smith RD; Slack M; Delpech VC
    AIDS; 2012 Jan; 26(1):87-94. PubMed ID: 22008657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
    Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
    J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Larsen CS; Jensen J; Obel N; Kronborg G
    Addiction; 2010 Mar; 105(3):529-35. PubMed ID: 20402997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005.
    Nyasulu P; Cohen C; De Gouveia L; Feldman C; Klugman KP; von Gottberg A;
    Pediatr Infect Dis J; 2011 Dec; 30(12):1075-80. PubMed ID: 21799459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: a nationwide cohort study*.
    Larsen MV; Harboe ZB; Ladelund S; Skov R; Gerstoft J; Pedersen C; Larsen CS; Obel N; Kronborg G; Benfield T
    HIV Med; 2012 Jan; 13(1):45-53. PubMed ID: 21819526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
    Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
    Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.